• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    AdaptHealth Appoints Crispin Teufel as New Chief Executive Officer

    6/27/23 8:16:00 AM ET
    $AHCO
    Medical/Nursing Services
    Health Care
    Get the next $AHCO alert in real time by email

    AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions, including home medical equipment, medical supplies and related services, announced today that its Board of Directors has named Crispin Teufel as Chief Executive Officer. Teufel is expected to assume the role on September 1, 2023.

    Crispin Teufel, 47, has served as the Chief Executive Officer of Lincare Holdings Inc., a leading national provider of in-home respiratory care with over 700 locations in 48 states, since July 2017. Previously, Mr. Teufel served as the Chief Financial Officer of Lincare from 2013 to 2019 and as a Finance Director for Linde Engineering in Germany from 2011 to 2013. Prior to joining Linde in 2005, Mr. Teufel began his career with financial roles at PWC and Arthur Andersen. Mr. Teufel currently serves on the Board of Directors of Bellerophon Therapeutics, a clinical-stage biotherapeutics company, and as the Chairman of the Board of the German American Chamber of Commerce of the South. Mr. Teufel holds an MBA in Economics from Ruhr University Bochum, Germany, is a Certified Public Accountant and is a German Tax Advisor.

    "We are quite pleased to be announcing the appointment of Crispin Teufel as the next Chief Executive Officer of AdaptHealth," said Mr. Barasch. "Crispin is the ideal candidate to lead AdaptHealth in its mission to transform care by keeping patients healthy in their homes. We are fortunate to have found such an experienced executive with deep industry understanding and a proven track record of success. The Board and I are confident that he will lead this organization to future success."

    "AdaptHealth has established itself as a leader in the industry and I am honored to be assuming the role of CEO at this pivotal time as the company enters the next era of at-home care. Together with the entire Adapt team and Board of Directors, I look forward to leveraging my expertise in the space to foster innovation and deliver value to the Company's customers and stakeholders," said Teufel.

    As previously announced, current CEO Stephen Griggs will step down effective June 30, 2023 and Richard Barasch, Chairman of the Board, will serve as interim CEO until Mr. Teufel joins the Company. Mr. Barasch will remain Chairman of the Board for AdaptHealth and will provide support through the transition.

    About AdaptHealth Corp.

    AdaptHealth is a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company provides a full suite of medical products and solutions designed to help patients manage chronic conditions in the home, adapt to challenges in their activities of daily living, and thrive. Product and service offerings include (i) sleep therapy equipment, supplies, and related services (including CPAP and bi PAP services) to individuals suffering from obstructive sleep apnea, (ii) medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors and insulin pumps), (iii) HME to patients discharged from acute care and other facilities, (iv) oxygen and related chronic therapy services in the home, and (v) other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs. The Company is proud to partner with an extensive and highly diversified network of referral sources, including acute care hospitals, sleep labs, pulmonologists, skilled nursing facilities, and clinics. AdaptHealth services beneficiaries of Medicare, Medicaid, and commercial insurance payors, reaching more than 3.9 million patients annually in all 50 states.

    Forward-Looking Statements

    This press release includes certain statements that are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "expect," "should," "would," "plan," "predict," "potential," "seem," "seek," "future," "outlook," and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding financial and performance metrics, and projections of market opportunity and expectations. These statements are based on various assumptions and on the current expectations of AdaptHealth management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on, by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of the Company.

    These forward-looking statements are subject to a number of risks and uncertainties, including the outcome of judicial and administrative proceedings to which the Company may become a party or governmental investigations to which the Company may become subject that could interrupt or limit the Company's operations, result in adverse judgments, settlements or fines and create negative publicity; changes in the Company's customers' preferences, prospects and the competitive conditions prevailing in the healthcare sector. A further description of such risks and uncertainties can be found in the Company's filings with the Securities and Exchange Commission. If the risks materialize or assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that the Company presently knows or that the Company currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect the Company's expectations, plans or forecasts of future events and views as of the date of this press release. The Company anticipates that subsequent events and developments will cause the Company's assessments to change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's assessments as of any date subsequent to the date of this press release. Accordingly, undue reliance should not be placed upon the forward-looking statements.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20230627968668/en/

    Get the next $AHCO alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AHCO

    DatePrice TargetRatingAnalyst
    1/8/2024$14.50 → $8.00Buy → Hold
    Jefferies
    11/8/2023$9.50 → $6.50Neutral → Underperform
    BofA Securities
    5/10/2023$28.00 → $11.30Buy → Hold
    Deutsche Bank
    5/10/2023$18.00 → $11.00Buy → Hold
    Stifel
    5/9/2023$21.00 → $12.00Buy → Neutral
    BofA Securities
    3/8/2022$31.00 → $26.00Outperform
    RBC Capital
    3/2/2022$32.00 → $24.00Outperform
    SVB Leerink
    2/18/2022$35.00 → $32.00Outperform
    SVB Leerink
    More analyst ratings

    $AHCO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    AdaptHealth downgraded by Jefferies with a new price target

    Jefferies downgraded AdaptHealth from Buy to Hold and set a new price target of $8.00 from $14.50 previously

    1/8/24 9:03:40 AM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    AdaptHealth downgraded by BofA Securities with a new price target

    BofA Securities downgraded AdaptHealth from Neutral to Underperform and set a new price target of $6.50 from $9.50 previously

    11/8/23 6:22:25 AM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    AdaptHealth downgraded by Deutsche Bank with a new price target

    Deutsche Bank downgraded AdaptHealth from Buy to Hold and set a new price target of $11.30 from $28.00 previously

    5/10/23 6:33:54 AM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    $AHCO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Lundberg Theodore B. was granted 29,210 shares, increasing direct ownership by 4% to 859,756 units (SEC Form 4)

    4 - AdaptHealth Corp. (0001725255) (Issuer)

    6/30/25 7:35:38 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    Director Connors Terence J was granted 21,346 shares, increasing direct ownership by 39% to 76,263 units (SEC Form 4)

    4 - AdaptHealth Corp. (0001725255) (Issuer)

    6/30/25 7:35:07 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    Director Weaver Susan T was granted 21,346 shares, increasing direct ownership by 29% to 94,818 units (SEC Form 4)

    4 - AdaptHealth Corp. (0001725255) (Issuer)

    6/30/25 7:34:48 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    $AHCO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    AdaptHealth Corp. Announces Second Quarter 2025 Results

    AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the second quarter ended June 30, 2025. Second Quarter Results and Highlights All comparisons are to the quarter ended June 30, 2024 unless otherwise stated. Net revenue was $800.4 million compared to $806.0 million, a decrease of 0.7%. Net income attributable to AdaptHealth Corp. was $14.7 million compared to net income of $19.4 million. Adjusted EBITDA was $155.5 million compared to $165.3 million, a decrease of 5.9%. Cas

    8/5/25 7:01:00 AM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    AdaptHealth Corp. Partners With a Major National Healthcare System to Become the Exclusive Provider of Home Medical Equipment

    AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, today announced that it has entered into a definitive agreement with a major national healthcare system. Under the agreement, AdaptHealth will serve as the exclusive provider of home medical equipment and supplies across the healthcare system's broad network of hospitals and medical offices. The 5-year agreement, which is subject to certain termination provisions, is structured primarily as a capitation payment model and covers all of the system's more than 10 million members.

    8/5/25 7:00:00 AM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    AdaptHealth Corp. to Participate in Upcoming Investor Conference

    AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that they will participate in the Canaccord Genuity 45th Annual Growth Conference, being held in Boston, on Wednesday, August 13, 2025, including a fireside chat at 8:00am ET. The webcast link will be available on the Company's website, www.adapthealth.com under "Investor Relations." About AdaptHealth Corp. AdaptHealth is a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and rel

    8/4/25 4:05:00 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    $AHCO
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by AdaptHealth Corp.

    SCHEDULE 13G - AdaptHealth Corp. (0001725255) (Subject)

    8/6/25 11:51:35 AM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    SEC Form 10-Q filed by AdaptHealth Corp.

    10-Q - AdaptHealth Corp. (0001725255) (Filer)

    8/5/25 5:09:33 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    AdaptHealth Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - AdaptHealth Corp. (0001725255) (Filer)

    8/5/25 7:11:34 AM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    $AHCO
    Leadership Updates

    Live Leadership Updates

    View All

    AdaptHealth Corp. Announces Appointment of Russell Schuster as Chief Commercial Officer

    AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that Russell Schuster has been appointed Chief Commercial Officer, effective December 2nd, 2024. In his new role, Mr. Schuster will oversee commercial strategy and revenue generation for the Company. He is a seasoned executive with more than 25 years of experience and a proven track record of growing large businesses. Most recently, Mr. Schuster served as President of Cardinal Health Canada, where he delivered meaningful performance improvement. Over eight ye

    12/3/24 8:00:00 AM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    AdaptHealth Appoints Diana Nole to Board of Directors

    AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, today announced the appointment of Diana Nole to the Board of Directors, effective October 16, 2024. "We are thrilled to welcome Diana to the AdaptHealth Board of Directors. Her extensive leadership experience in the healthcare technology sector caught our eye and we soon discovered that her decisive, resourceful leadership style and expertise in business transformation aligned perfectly with our current goals as an organization," said Dale Wolf, Chairman of the AdaptHealth B

    10/17/24 8:00:00 AM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    Advantage Healthcare Holdings Appoints Dinak Nair as Chief Executive Officer

    Advantage Healthcare Holdings ("Advantage" or the "Company"), a regional leader in providing patient-centered healthcare through managing and operating Comprehensive Outpatient Rehabilitation Facilities and Sleep Centers, announced that its Board of Directors has named Dinak (Dino) Nair as its Chief Executive Officer. Mr. Nair assumed leadership of the Company from the prior CEO, Ryan Tong, on September 1, 2024. Mr. Nair brings over 20 years of business experience, with more than a decade as a mission-driven leader growing businesses in the healthcare market, especially in homecare, home medical equipment, diagnostic laboratory, and health system partnerships. Mr. Nair most recently served

    9/25/24 11:19:00 AM ET
    $AHCO
    $LH
    Medical/Nursing Services
    Health Care
    Medical Specialities

    $AHCO
    Financials

    Live finance-specific insights

    View All

    AdaptHealth Corp. Announces Second Quarter 2025 Results

    AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the second quarter ended June 30, 2025. Second Quarter Results and Highlights All comparisons are to the quarter ended June 30, 2024 unless otherwise stated. Net revenue was $800.4 million compared to $806.0 million, a decrease of 0.7%. Net income attributable to AdaptHealth Corp. was $14.7 million compared to net income of $19.4 million. Adjusted EBITDA was $155.5 million compared to $165.3 million, a decrease of 5.9%. Cas

    8/5/25 7:01:00 AM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    AdaptHealth Corp. Announces Second Quarter 2025 Earnings Release Date and Conference Call

    AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its second quarter 2025 financial results before the opening of the financial markets on Tuesday, August 5, 2025. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts and investors. Interested parties may participate in the call by dialing: (800) 343-4136 (Domestic) or (203) 518-9843 (International) When prompted, reference Conference ID: AHCO2Q25 Webcast registration: Click Here Followin

    7/15/25 4:05:00 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    AdaptHealth Corp. Announces First Quarter 2025 Results

    AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the first quarter ended March 31, 2025. First Quarter Results and Highlights All comparisons are to the quarter ended March 31, 2024. Net revenue was $777.9 million compared to $792.5 million, a decrease of 1.8%. Net loss attributable to AdaptHealth Corp. was $7.2 million compared to net loss of $2.1 million. Adjusted EBITDA was $127.9 million compared to $158.5 million, a decrease of 19.3%. Cash flow from operations was $95.5 mi

    5/6/25 7:00:00 AM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    $AHCO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by AdaptHealth Corp.

    SC 13G/A - AdaptHealth Corp. (0001725255) (Subject)

    11/14/24 9:03:31 AM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G filed by AdaptHealth Corp.

    SC 13G - AdaptHealth Corp. (0001725255) (Subject)

    11/13/24 9:30:46 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by AdaptHealth Corp.

    SC 13G/A - AdaptHealth Corp. (0001725255) (Subject)

    11/12/24 1:30:20 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care